Toxicology of nutmeg abuse

Journal of Toxicology - Clinical Toxicology

Volumn 38, Issue 6, 2000, Pages 671-678

  Sangalli, B C ^a   Chiang, W ^a  

^a Phelps Memorial Hospital Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED CARBON; BORNEOL; CAMPHENE; CINEOLE; FURFURAL; GERANYL ACETATE; NUTMEG OIL; PINENE; SABINENE; TERPINENE;

ADOLESCENT; ARTICLE; ATAXIA; CASE REPORT; COLD SENSATION; DROWSINESS; FEMALE; GASTROINTESTINAL SYMPTOM; HALLUCINATION; HEADACHE; HUMAN; INTOXICATION; MUSCLE WEAKNESS; NAUSEA; NYSTAGMUS; PARESTHESIA; TOXICOLOGY; VISUAL IMPAIRMENT;

ADOLESCENT; CHARCOAL; FEMALE; HUMANS; SPICES; SUBSTANCE-RELATED DISORDERS;

ATAXIA; CANNABIS SATIVA; MYRISTICA FRAGRANS;

EID: 0033646419     PISSN: 07313810     EISSN: None     Source Type: Journal    
DOI: 10.1081/CLT-100102020     Document Type: Article

References (43)

1. Nutmeg as a psychoactive drug
2. The use of nutmeg as a psychotropic drug. Report of two cases
3. Hallucinogenic effects of nutmeg in adolescent
4. Hallucinogenic effect of nutmeg
5. Nutmeg poisoning - A case report
6. Acute psychosis associated with nutmeg toxicity
7. Acute nutmeg intoxication
8. Nutmeg intoxication
9. Acute nutmeg intoxication
10. The chemistry and psychopharmacology of nutmeg and of several related phenylisopropylamines
11. Possible implication of myristicin as a psychotropic substance
12. The chemistry and psychopharmacology of nutmeg and of several related phenylisopropylamines
13. The pharmacology of myristicin: A contribution to the psychopharmacology of nutmeg
14. Herbal preparations
15. Phencyclidine and the hallucinogens
16. Evidence for the biogenic formation of amphetamine derivatives from components of nutmeg
17. Urinary excretion of tertiary amino methoxy methylenedioxy propiophenones as metabolites of myristicin in the rat and guinea pig
18. Toxicological evaluation of myristicin
19. Metabolic changes of drugs and related organic compounds
20. Metabolism of alkenebenzene derivatives in the rat. II. Eugenol and isoeugenol methyl ethers
21. Metabolism of alkenebenzene derivatives in the rat. III. Elemicin and isoelemicin
22. Hydrolysis of the 2',3'-allylic epoxides of allylbenzene, estragole, eugenol, and safrole by both microsomal and cytosolic epoxide hydrolases
23. In vitro and in vivo metabolism of myristicin in the rat
24. Absorption, metabolism and excretion of safrole in the rat and man
25. The metabolism of eugenol in man
26. Neuropsychiatric illness and the metabolism of aromatic amino acids, trace amines, and substitute neurotransmitters
27. Structure - Activity relationships of one-ring psychotomimetics
28. Behavioral observations on compounds found in nutmeg
29. Pharmacologic evaluation of 3,4-dimethoxyphenylpropenes and 3,4-dimethoxyphenylpropanediols
30. Evidence of monoamine oxidase inhibition by myristicin and nutmeg
31. Do classical hallucinogens act as 5-HT2 agonists or antagonists?
32. Gamma-mangostin, a novel type of 5-hydroxytryptamine 2A receptor antagonist
33. Psychotrophic phenylisopropylamines derived from apiole and dillapiole
34. Pharmacological properties of magnolol and honokiol extracted from Magnolia officinalis: Central depressant effects
35. Kava extract ingredients, (+)- methysticin and (+/-)-kavain inhibit voltage-operated Na(+)-channels in rat CA1 hippocampal neurons
36. Toxicity of some essential plant oils. Clinical and experimental study
37. Alpha-thujone (the active component of absinthe): Gamma-aminobutyric acid type A receptor modulation and metabolic detoxification
38. In vitro inhibition of CYP2B1 monooxygenase by beta-myrcene and other monoterpenoid compounds